X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210117005066/en/Genkyotex-announces-positive-Phase-1-results-demonstrating-a-favorable-safety-and-pharmacokinetic-profile-of-high-dose-setanaxib
https://www.prnewswire.com/news-releases/calliditas-closes-acquisition-of-a-controlling-interest-in-genkyotex-sa-301165785.html